Veeva Systems stock analysis
Veeva Systems (0LO3) Share Price & Analysis
0LO3 Stock Chart & Stats
- Day’s Range
- $298.01 - $312.00
- 52-Week Range
- $148.70 - $330.00
- Previous Close
- $302.38
- Volume
- N/A
- Average Volume (3M)
- 1,378
- Market Cap
- $48.96B
- Enterprise Value
- $26.54B
- Total Cash (Recent Filing)
- $7.24B
- Total Debt (Recent Filing)
- $151.69M
- Price to Earnings (P/E)
- 48.6
- Beta
- 0.70
- Next Earnings
- Dec 03, 2026 (Est.)
- EPS Estimate
- 2.34
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
High Profitability And Cash Conversion
Veeva converts its subscription-oriented software model into strong profitability, with high gross and net margins supported by recurring customer revenue. Cash flow closely tracks earnings, giving the company durable capacity to fund product development, strategic investments, and growth without relying heavily on external capital.
Conservative Balance Sheet
Minimal leverage materially reduces financial risk and preserves flexibility through changing industry conditions. Veeva can continue investing in cloud products, data, and artificial intelligence while retaining the ability to absorb execution setbacks or pursue opportunities without significant debt-service constraints.
Strong Life-sciences Platform Position
Record CRM performance and wins with major biopharma customers reinforce Veeva’s position within a specialized, highly regulated market. Expanding adoption across Vault CRM and related applications can deepen platform relationships, support cross-selling, and make Veeva’s systems more embedded in customer workflows.
Bears Say
Material Revenue Growth Deceleration
The sharp slowdown in revenue growth indicates that Veeva is operating from a more mature base and faces a tougher path to reacceleration. Even with strong margins, slower expansion can limit operating leverage, reduce the pace of market penetration, and increase dependence on successful new products.
AI Monetization And Margin Uncertainty
Veeva’s AI opportunity is promising but its commercial model is not yet proven. Unsettled pricing structures may delay monetization, while elevated model-compute costs could dilute software margins before efficiencies or lower-cost models emerge, making returns on AI investment less predictable.
Customer-facing Leadership Transition
The transition removes an experienced executive credited with significant contributions to Veeva and its customers, creating an execution risk across sales and services. Although a successor has been appointed and partner ties remain, maintaining customer relationships and momentum will be important during the handover.
Veeva Systems News
0LO3 FAQ
What was Veeva Systems’s price range in the past 12 months?
What is Veeva Systems’s market cap?
When is Veeva Systems’s upcoming earnings report date?
How were Veeva Systems’s earnings last quarter?
Is Veeva Systems overvalued?
Does Veeva Systems pay dividends?
What is Veeva Systems’s EPS estimate?
How many shares outstanding does Veeva Systems have?
What happened to Veeva Systems’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Veeva Systems?
What is the TipRanks Smart Score and how is it calculated?
Veeva Systems Stock Smart Score
Company Description
Veeva Systems
Veeva Systems Inc. is a leading provider of cloud-based software solutions, exclusively dedicated to the global life sciences industry. Its extensive operational presence spans across North America, Europe, the Asia Pacific region, the Middle East, Africa, and Latin America. The company's product portfolio is primarily structured around two major offerings. First, the Veeva Commercial Cloud delivers an integrated suite of software, data, and analytics tools designed to optimize commercial operations. This includes vital applications such as Veeva Customer Relationship Management (CRM) and its specialized Medical CRM, Veeva Closed Loop Marketing (CLM), sophisticated analytics via Veeva CRM MyInsights, approved email communication with Veeva CRM Approved Email, digital engagement tools like Veeva CRM Engage, commercial alignment through Veeva Align, event management capabilities with Veeva CRM Events Management, data warehousing solutions (Veeva Nitro), data services (Veeva OpenData, Veeva Link), master data management (Veeva Network), advanced analytical insights (Veeva Crossix, Veeva Data Cloud), and patient engagement platforms (MyVeeva for Patients). Secondly, Veeva Vault provides a robust collection of cloud-native enterprise content and data management applications. These applications are engineered to support both critical commercial functions—encompassing sales, marketing, and medical content and communications—and comprehensive research and development processes, including clinical trials, regulatory compliance, quality management, and patient safety. Beyond its software, Veeva offers a wide array of professional and support services. These range from strategic implementation and deployment planning, project management, and detailed requirements analysis to solution design and configuration. They also include system environment management and deployment, expert consulting for business process transformation related to Veeva solutions, technical guidance on data migration and systems integrations, comprehensive training programs, and ongoing managed services such as outsourced systems administration. Tracing its origins, the company was incorporated in 2007 as Verticals onDemand, Inc., and subsequently rebranded to Veeva Systems Inc. in April 2009. Its corporate headquarters are situated in Pleasanton, California.
- Sector
- Healthcare
- Industry
- Software - Application
- CEO
- Peter Gassner
- Employees
- 7,928
- Website
- www.veeva.com
- Address
- 4280 Hacienda Drive, Pleasanton, CA, 94588, US
Veeva Systems (0LO3) Earnings & Revenues
0LO3 Company Deck
0LO3 Earnings Call
Earnings Call SentimentPositive
The call communicated a predominantly positive operational and financial performance: revenue of $928M, non-GAAP operating income of $416M (~44.8% margin), strong commercial subscription growth (~13% YoY), record CRM results, and meaningful early traction in AI (Falcon) and Data Cloud. Management raised guidance and highlighted selective, disciplined investments (Aspen) and a healthy IQVIA partnership. Key risks centered on execution and timing for agentic AI (product readiness, onboarding capacity, pricing models), potential model-compute cost pressure, and staggered timing of R&D product ramps. Overall, highlights (strong revenue/profitability, CRM wins, AI interest, Data Cloud additions, guidance raise) materially outweigh the manageable near-term execution and timing lowlights.
View all GB:0LO3 earnings summaries0LO3 Net sales Breakdown
- 58.18% North America
- 27.79% Europe
- 11.35% APAC
- 2.68% Middle East, Africa, and Latin America
0LO3 Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 9 | 5 | 8 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 6 | 0 | 6 |











